Objective: To examine the occurrence of bladder spasms following surgical repair of urogenital fistula.
Methods: The present retrospective study included data from patients who underwent surgical repair of urogenital fistula at the National Obstetric Fistula Centre, Abakaliki, Nigeria, between June 1, 2015, and May 31, 2016. Patients who underwent rectovaginal fistula repair and those who experienced persistent postoperative pain requiring high doses of analgesia were excluded. Bladder spasm was defined as the sudden onset of intermittent pain in the region of the bladder lasting for short periods of time in patients who were previously comfortable with routine postoperative analgesia. The incidence of bladder spasm was calculated and the presence of an association between repair outcome and bladder spasms was investigated.
Results: There were 133 patients included in the present study with a mean age of 36 ± 11 years. Bladder spasms were experienced by 60 (45.1%) patients during the study period; of these patients, failed fistula repair was recorded for 13 (22%). Good surgical outcome (closed fistula) was associated with not experiencing postsurgical bladder spasms (P=0.044).
Conclusion: The incidence of bladder spasm following surgical repair of urogenital fistula appeared high. The occurrence of bladder spasms could influence repair outcomes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/ijgo.12226 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
FDA Approval Summary: Nadofaragene firadenovec-vncg for bacillus Calmette-Guérin-unresponsive non-muscle invasive bladder cancer.
Clin Cancer Res
December 2024
United States Food and Drug Administration, Silver Spring, Maryland, United States.
On December 16, 2022, the FDA approved the adenoviral vector-based gene therapy nadofaragene firadenovec-vncg (brand name Adstiladrin) for the treatment of adult patients with high-risk bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS). The product represents the first approved adenoviral vector-based gene therapy and the first approved gene therapy for bladder cancer. Determination of efficacy was based on results from Study rAd-IFN-CS-003 (Study CS-003), a single-arm trial in 98 evaluable patients with BCG-unresponsive NMIBC with CIS who received intravesical instillations of the gene therapy product (75 mL of nadofaragene firadenovec at 3 × 1011 viral particles per mL) once every 3 months.
View Article and Find Full Text PDFAnalysis of postoperative complications in bladder cancer patients.
Open Med (Wars)
November 2024
Department of Urology, Huzhou Central Hospital, Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, No. 1558, Sanhuan North Road, Wuxing District, Huzhou, Zhejiang, 313000, China.
Background: Bladder cancer, a significant health concern worldwide, often necessitates diverse surgical interventions and postoperative treatments. Understanding the complications arising from these procedures is vital for enhancing patient outcomes and quality of life.
Methods: This study encompassed 80 bladder cancer patients, evaluating their demographic characteristics, systemic conditions, cancer stages, tumor diameter, surgical procedures, and postoperative treatments.
Symptomatic Pneumorrhachis from Bronchial-Subarachnoid Fistula.
Diagnostics (Basel)
September 2024
Department of Radiology, Mayo Clinic, Phoenix, AZ 85054, USA.
Bronchial-subarachnoid fistulas are rare occurrences, which are not well defined in the literature. This uncommon clinical phenomenon may result in symptomatic pneumorrhachis and presents unique clinical challenges. This report details a case of a 53-year-old female whose treatment for recurrent chondrosarcoma of the thoracic spine included multiple surgeries and radiotherapy.
View Article and Find Full Text PDFDevelopment and evaluation of a spaced eLearning intervention for nurses in enhancing urinary catheter management - A co-design study in partnership with research end-users.
Nurse Educ Today
January 2025
School of Nursing, Faculty of Science, Medicine & Health, University of Wollongong, Australia, Australian Centre for Integration of Oral Health (ACIOH), Ingham Institute for Applied Medical Research, Building 41: Room 118, University of Wollongong, NSW, 2522, Australia. Electronic address:
Background: Nurses play a critical role in supporting patients in self-managing their indwelling urinary catheters and preventing avoidable hospital presentations. This study aimed to explore the effectiveness of a co-designed educational approach developed to enhance nurses' ability to provide optimal care for patients with catheters.
Aim: The primary aim of this study was to enhance nurses' knowledge and skills in urinary catheterisation, care, and management.
Acute Paraplegia Following Spinal Anesthesia in a Patient With Unrecognized Thoracic Ossification of the Posterior Longitudinal Ligament and Spinal Stenosis: A Case Report.
Cureus
September 2024
Neurosurgery, Taipei Veterans General Hospital, Taipei, TWN.
Article Synopsis
- Spinal coning is a serious and rare complication of spinal anesthesia that can lead to sudden neurological issues due to changes in cerebrospinal fluid (CSF) flow, especially in patients with spinal stenosis.
- A case study involving a 50-year-old woman highlights that after receiving spinal anesthesia for urethral treatment, she experienced acute paraplegia and loss of bladder function due to undiagnosed severe spinal stenosis.
- The article emphasizes the importance for medical professionals to be cautious about pre-existing spinal conditions before administering spinal anesthesia, as timely surgical intervention can greatly improve patient outcomes.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!